DSpace Repositorium (Manakin basiert)

Psychopharmacology of smoking cessation medications: focus on patients with mental health disorders

Zur Kurzanzeige

dc.contributor.author Castaldelli-Maia, João Mauricio
dc.contributor.author Camargos de Oliveira, Victoria
dc.contributor.author Irber, Flávia Mariana
dc.contributor.author Blaas, Israel Kanaan
dc.contributor.author Angerville, Bernard
dc.contributor.author Sousa Martins da Silva, Anderson
dc.contributor.author Koch Gimenes, Gislaine
dc.contributor.author Waisman Campos, Marcela
dc.contributor.author Torales, Julio César
dc.contributor.author Ventriglio, Antonio
dc.contributor.author Guillois, Carine
dc.contributor.author El Ouazzani, Houria
dc.contributor.author Gazaix, Léna
dc.contributor.author Favré, Pascal
dc.contributor.author Dervaux, Alain
dc.contributor.author Apter, Gisèle
dc.date.accessioned 2024-02-27T15:18:44Z
dc.date.available 2024-02-27T15:18:44Z
dc.date.issued 2023-09-05
dc.identifier.citation Castaldelli-Maia JM, Camargos de Oliveira V, Irber FM, Blaas IK, Angerville B, Sousa Martins-da-Silva A, et al. Psychopharmacology of smoking cessation medications: focus on patients with mental health disorders. Int Rev Psychiatry. 2023;35(5-6):397-417. es_ES
dc.identifier.uri https://doi.org/10.1080/09540261.2023.2249084
dc.identifier.uri https://repositorio.fleni.org.ar/xmlui/handle/123456789/1021
dc.description.abstract The adverse effects of smoking cessation in individuals with mental health disorders have been a point of concern, and progress in the development of treatment has been slow. The primary first-line treatments for smoking cessation are Nicotine Replacement Therapy, Bupropion, Varenicline, and behavioural support. Nortriptyline and Clonidine are second-line treatments used when the first-line treatments are not effective or are contraindicated. Smoking cessation medications have been shown to be effective in reducing nicotine cravings and withdrawal symptoms and promoting smoking cessation among patients living with mental disorders. However, these medications may have implications for patients' mental health and need to be monitored closely. The efficacy and side effects of these medications may vary depending on the patient's psychiatric condition, medication regimen, substance use, or medical comorbidities. The purpose of this review is to synthesise the pharmacokinetics, pharmacodynamics, therapeutic effects, adverse effects, and pharmacological interactions of first- and second-line smoking cessation drugs, with an emphasis on patients suffering from mental illnesses. Careful consideration of the risks and benefits of using smoking cessation medications is necessary, and treatment plans must be tailored to individual patients' needs. Monitoring symptoms and medication regimens is essential to ensure optimal treatment outcomes. es_ES
dc.language.iso eng es_ES
dc.publisher Informa Healthcare es_ES
dc.subject Benzazepines es_ES
dc.subject Benzazepinas es_ES
dc.subject Mental Health es_ES
dc.subject Salud Mental es_ES
dc.subject Nicotinic Agonists es_ES
dc.subject Agonistas Nicotínicos es_ES
dc.subject Psychopharmacology es_ES
dc.subject Psicofarmacología es_ES
dc.subject Quinoxalines es_ES
dc.subject Quinoxalinas es_ES
dc.subject Smoking Cessation es_ES
dc.subject Cese del Hábito de Fumar es_ES
dc.subject Substance Withdrawal Syndrome es_ES
dc.subject Síndrome de Abstinencia a Sustancias es_ES
dc.subject Tobacco Use Cessation Devices es_ES
dc.subject Dispositivos para Dejar de Fumar Tabaco es_ES
dc.title Psychopharmacology of smoking cessation medications: focus on patients with mental health disorders es_ES
dc.type info:eu-repo/semantics/article es_ES
dc.description.fil Fil: Waisman Campos, Marcela. Fleni. Departamento de Neurología. Servicio de Neurología Cognitiva, Neuropsicología y Neuropsiquiatría; Argentina.
dc.relation.ispartofVOLUME 35
dc.relation.ispartofNUMBER 5-6
dc.relation.ispartofPAGINATION 397-417
dc.relation.ispartofCOUNTRY Reino Unido
dc.relation.ispartofCITY Londres
dc.relation.ispartofTITLE International review of psychiatry
dc.relation.ispartofISSN 1369-1627
dc.type.snrd info:ar-repo/semantics/artículo es_ES


Dateien zu dieser Ressource

Das Dokument erscheint in:

Zur Kurzanzeige

DSpace Suche


Stöbern

Mein Benutzerkonto

Statistik